Indigestion Completed Phase 3 Trials for Rifabutin (DB00615)

Also known as: Dyspepsia

IndicationStatusPhase
DBCOND0031004 (Indigestion)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03198507ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active ComparatorTreatment